Metraipolis › archive › dc_ca8634f60d06

Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a… — Europe PMC PMID:42395119

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42395119
DOI
10.1002/ags3.70202
License (as archived)
solo-consultazione
Archived
2026-11-05T14:03:09.572Z
SHA-256 of the archived text
543d7bd59bad1e73060420f7903716913e4c991358283c10bb6190ca7207d8c6
Stable URL of this page
https://metraipolis.com/documento/dc_ca8634f60d06

How to cite

Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a… — Europe PMC PMID:42395119 — Europe PMC (en), https://europepmc.org/article/MED/42395119 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca8634f60d06 (Metraipolis archive dc_ca8634f60d06, sha256 543d7bd59bad1e73060420f7903716913e4c991358283c10bb6190ca7207d8c6)
BibTeX
@misc{dcca8634f60d06,
  title = {Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a… — Europe PMC PMID:42395119},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42395119},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca8634f60d06; sha256 543d7bd59bad1e73060420f7903716913e4c991358283c10bb6190ca7207d8c6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42395119. Agents can read the archived copy with the MCP tool read_document.